All Themes
Trending themes from expert articles and discussions (last 30 days)
Policy & Regulatory Changes
CMS is pushing a more prescriptive value-based care agenda through the CY 2027 Physician Fee Schedule/MSSP final rule, with changes aimed at strengthening ACO participation, primary care payment, prevention, duplicate-billing controls, and reduced administrative burden—signaling that the Trump administration’s CMS under Dr. Mehmet Oz is continuing to use rulemaking to steer providers from MIPS-style reporting toward accountable care infrastructure ([PFS/MSSP final rule summary](https://www.hcinnovationgroup.com/policy-value-based-care/medicare-medicaid/news/55417036/cms-finalizes-2027-physician-fee-schedule-with-changes-to-primary-care-acos-and-billing)). At the same time, CMMI’s mandatory-model posture is creating operational pushback: hospitals and specialty groups are preparing for CJR-X and challenging the rollout pace of the Ambulatory Specialty Model for back pain and heart failure, reflecting a widening tension between CMS’s desire for specialty-cost accountability and providers’ concerns over readiness, downside risk, and attribution mechanics ([Ambulatory Specialty Model concerns](https://www.hcinnovationgroup.com/policy-value-based-care/alternative-payment-models/news/55414957/groups-call-for-delay-to-ambulatory-specialty-model-roll-out)). For ACOs, health systems, and payers, the strategic throughline is clear: Medicare VBC is becoming less optional and more operationally demanding, requiring stronger episode analytics, specialty alignment, coding
Healthcare Affordability
CMS’s affordability agenda is increasingly centered on mandatory and episode-based payment models: hospitals are preparing for the TEAM model’s operational requirements, while CJR-X and BPCI Advanced results are reinforcing the case for population-health infrastructure, post-acute management, and specialist alignment—even as proposed surgeon payment cuts create tension between Medicare savings goals and provider participation incentives. At the same time, affordability pressure is broadening beyond Medicare FFS into Medicaid and MA: the BALANCE Model raises the question of how states can expand GLP-1 access sustainably, while Star Ratings litigation and prior authorization reform efforts signal intensifying scrutiny of payer incentives, administrative burden, and benefit design. For ACOs and VBC organizations, the strategic takeaway is that CMS under the Trump administration is likely to keep pushing risk-bearing models and AI-enabled efficiency, but success will depend on whether providers can translate episode savings into durable physician engagement and patient access protections ([TEAM model preparation](https://www.healthcare-brew.com/stories/rainfall-health-hospitals-navigate-cms-team-model?utm_source=&utm_medium=syndication&utm_campaign=feed); [BALANCE Medicaid GLP-1 model](https://www.healthaffairs.org/content/forefront/expanding-glp-1-access-under-balance-model-supporting-sustainable-medicaid)).
VBC Market Dynamics
VBC market activity is concentrating around two pressure points: Medicare Advantage payment integrity and risk adjustment volatility, and Medicaid affordability for high-cost therapies. MA plans are aggressively contesting CMS’ 2027 Star Ratings methodology—Aetna says more than $2B is at stake and Centene estimates a $448M hit—while KFF data show 4.3M beneficiaries face MA or Part D plan terminations at the end of 2026, signaling continued benefit redesign, market exits, and network disruption for providers tied to MA value-based contracts ([Aetna lawsuit](https://www.healthcarefinancenews.com/news/aetna-sues-cms-over-star-ratings-citing-more-2b-stake); [KFF plan terminations](https://www.kff.org/medicare/more-than-4-million-medicare-beneficiaries-will-have-their-medicare-advantage-or-stand-alone-prescription-drug-plan-terminated-at-the-end-of-2026/)). At the same time, Privia’s $36M acquisition of American Choice Healthcare’s MSSP business points to continued consolidation around ACO infrastructure, while Health Affairs’ focus on GLP-1 access under the BALANCE Model and social risk adjustment underscores a broader shift: VBC stakeholders are pushing for payment models that can absorb expensive therapeutics and account for patient complexity without penalizing providers serving higher-risk populations.
Value-Based Contracting
CMS is pushing VBC further into mandatory and specialty-focused risk: the CY 2027 Physician Fee Schedule/MSSP final rule advances ACO and primary care changes while signaling a broader shift away from fragmented fee-for-service toward prevention, reduced duplicate billing, and streamlined quality incentives ([CMS finalizes CY 2027 PFS/MSSP changes](https://www.hcinnovationgroup.com/policy-value-based-care/medicare-medicaid/news/55417036/cms-finalizes-2027-physician-fee-schedule-with-changes-to-primary-care-acos-and-billing)). At the same time, provider groups are pressing for delays or operational relief around new models such as the Ambulatory Specialty Model, while hospitals are preparing for CJR-X’s Jan. 1, 2028 mandatory joint-replacement episodes—evidence that the Trump administration’s CMS is pairing MSSP refinements with more compulsory episode-based accountability ([CJR-X preparation](https://premierinc.com/newsroom/insights/10-things-hospital-leaders-need-to-know-about-cjr-x)). For health systems, ACOs, and payers, the strategic imperative is to harden specialty care management, episode analytics, and physician alignment now, because downside-risk exposure is expanding beyond primary care and total-cost-of-care ACO contracts into service-line-specific Medicare payment models.
Care Coordination
CMS’s move under the Trump administration toward mandatory and episode-based models is putting care coordination back at the center of VBC strategy: hospitals are preparing for CJR-X and TEAM-style bundled payment requirements that shift financial risk to surgical and procedural episodes, requiring tighter post-acute management, referral alignment, and longitudinal population-health infrastructure rather than discharge-only coordination ([Premier on CJR-X](https://premierinc.com/newsroom/insights/10-things-hospital-leaders-need-to-know-about-cjr-x); [Healthcare Brew on TEAM](https://www.healthcare-brew.com/stories/rainfall-health-hospitals-navigate-cms-team-model)). At the same time, physician groups are pushing back on new Medicare models for back pain and heart failure, underscoring a strategic tension for ACOs and health systems: CMS is expanding accountability for total-cost and outcomes performance, but provider readiness, specialty alignment, and workflow burden remain uneven—especially as Medicaid experiments such as North Carolina’s rural primary care capitation pilot point toward broader payer interest in prospective, team-based care models.
Health IT & Interoperability
CMS’ late-2026 rulemaking is pushing VBC infrastructure from retrospective reporting toward real-time, standards-based operations: ACOs are being steered toward HL7 FHIR-based quality reporting, while payers face near-term CMS-0057-F prior authorization API deadlines that will force workflow redesign across plans, EHRs, and provider revenue-cycle teams. The strategic tension is execution risk—groups such as MGMA are pressing CMS to delay ASM implementation, while ACOs and specialty networks must invest in interoperability, data governance, and automation fast enough to support Medicare payment updates, TEAM-related specialty management, MA Stars changes, and tighter prior authorization accountability. For ACOs, the practical implication is that today’s care-management and analytics stack may not be sufficient for the next phase of CMS-aligned contracting and reporting, particularly as FHIR quality reporting and prior authorization APIs become core operating rails rather than compliance side projects ([FHIR for ACO quality reporting](https://leavittpartners.com/modernizing-aco-quality-reporting-with-hl7-fhir/); [prior authorization API readiness](https://www.forvismazars.us/forsights/2026/10/cms-0057-f-adapting-workflows-for-prior-authorization-apis)).
Quality Metrics
CMS is using the CY 2027 Physician Fee Schedule and Quality Payment Program rule to tighten the link between quality measurement, primary care investment, ACO performance, and billing integrity—finalizing changes that accelerate prevention-oriented value-based care while advancing the sunset of traditional MIPS and modifying MSSP/ACO policies ([CMS CY 2027 PFS final rule](https://www.hcinnovationgroup.com/policy-value-based-care/medicare-medicaid/news/55417036/cms-finalizes-2027-physician-fee-schedule-with-changes-to-primary-care-acos-and-billing)). At the same time, provider groups are pushing back on mandatory specialty and episode-based models—including the Ambulatory Specialty Model and upcoming CJR-X—arguing that quality metrics, attribution, and implementation timelines may outpace operational readiness and create downside risk without sufficient adjustment for clinical complexity. Medicare Advantage quality measurement is also under stress, with payers suing over 2027 Star Ratings, signaling that CMS’s broader quality agenda is becoming a contested financial battleground across ACOs, MA plans, and specialty-model participants ([MA Star Ratings lawsuits](https://ramaonhealthcare.com/10-payers-suing-over-2027-medicare-advantage-star-ratings/)).
Payment Integrity
Payment integrity is shifting from retrospective fraud control toward front-end algorithmic and measurement governance: CMS’s 2027 Physician Fee Schedule changes affect primary care billing, ACO participation, and documentation incentives, while providers are increasingly scrutinizing ACO shared-savings calculations and benchmark mechanics as material revenue-risk issues. At the same time, Medicare Advantage payment integrity is being litigated through Star Ratings, with Centene, Elevance, Jefferson Health, and other payers challenging CMS methodology and alleged use of voided measures—raising broader questions about whether quality-payment formulas are transparent, legally durable, and operationally predictable for risk-bearing organizations. The strategic tension for VBC stakeholders is clear: CMS under the Trump administration is pursuing tighter oversight, automation, and savings capture, but plans and providers are pushing back where payment integrity tools intersect with prior authorization burden, AI-enabled denials, ACO reconciliation, and MA quality bonuses ([2027 PFS/ACO changes](https://www.hcinnovationgroup.com/policy-value-based-care/medicare-medicaid/news/55417036/cms-finalizes-2027-physician-fee-schedule-with-changes-to-primary-care-acos-and-billing); [MA Star Ratings litigation](https://www.modernhealthcare.com/insurance/mh-elevance-medicare-advantage-star-ratings-lawsuit/)).
Population Health Management
Population health management is being pulled deeper into payment-model infrastructure: ACO leaders are emphasizing operational playbooks for attributed-patient management, while Leavitt Partners is pushing HL7® FHIR®-based ACO quality reporting as a path to reduce reporting burden and make performance measurement more real-time for MSSP and other accountable-care participants ([FHIR ACO reporting](https://leavittpartners.com/modernizing-aco-quality-reporting-with-hl7-fhir/)). The strategic center of gravity is also shifting toward prevention, longitudinal care coordination, and physician-led governance in alternative payment models, with renewed attention to embedding prevention into CMMI model design and tying care coordination more directly to clinical outcomes ([prevention in APMs](https://www.healthaffairs.org/content/forefront/embedding-prevention-alternative-payment-models-cms-innovation-center)). At the same time, consolidation and vertical alignment are accelerating—e.g., Privia’s acquisition of an MSSP business and MultiCare’s “payvider” Medicare Advantage strategy—signaling that providers and payers are positioning for tighter control over attribution, risk, data, and network performance as CMS under the Trump administration continues to shape the next phase of VBC.
Health Equity & SDoH
Health equity and SDoH strategy is shifting from broad programmatic add-ons toward harder-edged payment design: social risk adjustment is becoming central to VBC debates as CMS, states, ACOs, and Medicaid managed care plans confront whether quality benchmarks and shared-savings targets should explicitly account for housing, food insecurity, disability, and neighborhood-level deprivation ([Health Affairs](https://www.healthaffairs.org/content/forefront/advancing-social-risk-adjustment-value-based-payment)). At the same time, Medicaid is moving into a more restrictive and legally contested operating environment under the Trump administration, with work requirements, 1115 waiver budget-neutrality changes, and litigation over medical frailty exemptions creating new churn, access, and attribution risks for providers managing high-need populations ([KFF](https://www.kff.org/medicaid/1115-waiver-watch-a-look-at-budget-neutrality-policy-changes/)). For VBC stakeholders, the strategic tension is widening: payment models are increasingly expected to reward equity-sensitive outcomes and population health management, while Medicaid eligibility instability and benefit redesign may weaken the continuity and data reliability those models require.
Drug Pricing
CMS is pushing drug-pricing reform deeper into managed care operations, with proposals targeting Medicare Advantage provider directory accuracy, PBM transparency, and drug-cost reduction—moves that would increase plan accountability and may reshape MA-PD contracting, formulary strategy, and pharmacy network economics for VBC organizations ([AHA summary](https://www.aha.org/news/headline/2026-10-19-cms-issues-proposals-improve-ma-plan-provider-directory-accuracy-pbm-transparency-requirements-and)). At the same time, Medicare market disruption is accelerating: 4.3 million beneficiaries are slated to lose MA drug or stand-alone Part D plans at the end of 2026, creating near-term retention, risk-coding, medication adherence, and care-continuity challenges for ACOs, MA plans, and provider groups managing senior populations ([KFF analysis](https://www.kff.org/medicare/more-than-4-million-medicare-beneficiaries-will-have-their-medicare-advantage-or-stand-alone-prescription-drug-plan-terminated-at-the-end-of-2026/)). Medicaid and specialty-drug affordability are also moving toward model-based solutions, with GLP-1 access under the BALANCE Model and the 340B rebate dispute signaling a broader shift from unit-price fights toward budget predictability, pharmacy-channel control, and outcomes-linked access for high-cost therapies.
Primary Care Models
CMS’s Trump-era 2027 Medicare Physician Fee Schedule final rule is signaling a primary-care payment reset: the agency is moving away from G2211 toward new B1/B2 visit complexity constructs while also making ACO and billing changes that will affect attribution, coding strategy, and shared-savings economics for Medicare value-based care participants ([PFS primary care/ACO changes](https://www.hcinnovationgroup.com/policy-value-based-care/medicare-medicaid/news/55417036/cms-finalizes-2027-physician-fee-schedule-with-changes-to-primary-care-acos-and-billing)). At the same time, Medicaid is testing more explicit primary-care capitation through North Carolina’s rural practice pilot, reinforcing a broader payer shift from visit-based support toward prospective, population-based primary care financing for under-resourced markets ([NC Medicaid rural capitation pilot](https://www.hcinnovationgroup.com/policy-value-based-care/medicare-medicaid/article/55417914/nc-medicaid-to-launch-primary-care-capitation-pilot-for-rural-practices)). For ACOs, independent practices, and health systems, the strategic tension is whether these new payment constructs meaningfully fund longitudinal primary care and care management—or simply create new documentation, benchmark, and shared-savings calculation risks without stabilizing operating margins.
Medicare Advantage Stars
Medicare Advantage Stars have shifted from a quality-improvement scorecard into a high-stakes payment litigation arena, with at least 10 payers challenging CMS calculations for 2027 ratings and alleging that voided or improperly applied measures could cost plans billions in bonus payments and rebates. CVS/Aetna’s suit claims a potential [$2B MA Stars hit](https://www.healthcaredive.com/news/cvs-aetna-lawsuit-medicare-advantage-star-ratings-2027-cms-2-billion/873000/), while Centene, Elevance, Jefferson Health and others are pursuing similar recalculations, underscoring how Stars methodology now directly shapes plan bids, supplemental benefits, provider risk contracts, and downstream VBC economics. For ACOs, delegated provider groups, and payer partners, the strategic implication is clear: MA value-based arrangements increasingly need tighter governance around CAHPS, medication adherence, data validation, and contract protections tied to CMS rating disputes, as the Trump administration’s CMS faces pressure to stabilize Star Ratings policy while defending payment integrity [amid escalating insurer lawsuits](https://www.healthcaredive.com/news/centene-medicare-advantage-stars-lawsuit-cms-2027/833922/).
Risk Adjustment & Coding
CMS is tightening the operating environment for Medicare value-based care by finalizing CY 2027 Medicare Physician Fee Schedule/MSSP changes that strengthen the Medicare Shared Savings Program while reducing some administrative burden, even as ACO stakeholders continue pressing Congress for more durable incentives and program reforms beyond what CMS can do alone ([Premier on CY 2027 PFS/MSSP final rule](https://premierinc.com/newsroom/policy/statement-pfs-mssp-cy2027-final-rule)). At the same time, mandatory episodic risk is expanding through CJR-X, putting 2,217 hospitals under renewed pressure to improve coding accuracy, episode-cost management, post-acute steering, and physician alignment—signals that risk adjustment, documentation integrity, and longitudinal care coordination are becoming core strategic capabilities rather than back-office functions ([Premier on CJR-X](https://premierinc.com/newsroom/insights/10-things-hospital-leaders-need-to-know-about-cjr-x)).
ACO REACH & MSSP
CMS under the Trump administration is using the CY 2026 Physician Fee Schedule/MSSP final rule to keep pushing Medicare ACO policy toward more durable value-based infrastructure: strengthening the Medicare Shared Savings Program, reducing reporting and billing friction, and aligning primary care and quality measurement reforms with broader prevention and population-health goals ([CMS CY 2026 PFS/MSSP final rule coverage](https://www.hcinnovationgroup.com/policy-value-based-care/medicare-medicaid/news/55417036/cms-finalizes-2026-physician-fee-schedule-with-changes-to-primary-care-acos-and-billing)). The strategic tension is shifting from whether MSSP should grow to how CMS balances participation incentives, downside-risk progression, benchmark stability, digital quality reporting, and duplicate-billing controls without undermining provider willingness to stay in or enter accountable care. In parallel, ACO REACH remains the more flexible, higher-risk alternative to MSSP for organizations prepared to manage prospective payments, health equity requirements, and advanced population-health operations, reinforcing a bifurcated ACO market between broad MSSP participation and more capital-intensive model-based transformation ([ACO REACH vs. MSSP overview](https://casrai.org/guides/aco-reach-model)).
Bundled Payments
CMS’s bundled-payment strategy is shifting from voluntary participation to broader mandatory episode risk, with hospitals preparing for TEAM and the Jan. 1, 2026 launch of CJR-X, a mandatory lower-extremity joint replacement model expected to affect more than 2,200 hospitals and force tighter alignment across surgeons, post-acute providers, and population health infrastructure ([Premier on CJR-X readiness](https://premierinc.com/newsroom/insights/10-things-hospital-leaders-need-to-know-about-cjr-x)). The strategic tension for VBC stakeholders is that CMS is using proven savings from BPCI Advanced and CJR to justify expansion and redesign of episode-based payment, while hospitals and specialty groups are pushing back on mandatory risk, physician payment pressure, and operational readiness requirements—especially as ACOs must decide how bundled episodes interact with MSSP/ACO REACH total-cost accountability ([CASRAI comparison of ACO REACH, MSSP, and BPCI Advanced](https://casrai.org/guides/aco-reach-model)).
Healthcare Operations
Healthcare operations are shifting from back-office optimization to payment-risk infrastructure as Medicaid eligibility changes under OBBBA threaten to create a new uncompensated-care and coverage-churn shock, forcing health systems, ACOs, and safety-net providers to harden patient access, employment verification, and revenue-cycle workflows before denials translate into avoidable bad debt and care fragmentation ([OBBBA revenue cycle shockwave](https://www.healthcareittoday.com/2026/11/10/preparing-for-the-obbba-revenue-cycle-shockwave-strategies-outlined-at-hps26/)). At the same time, providers are escalating AI and automation investments in revenue cycle management to counter payer denials, underpayments, and audits—turning claims appeals, prior authorization, and contract compliance into strategic capabilities for organizations operating under VBC downside risk ([AI arms race in RCM](https://www.hfma.org/technology/the-ai-arms-race-reaches-revenue-cycle-management-how-leaders-are-responding/)). The throughline is that operational resilience—real-time data, transparent unit-cost accounting, and AI-enabled revenue integrity—is becoming a prerequisite for sustaining population health models as federal policy, payer behavior, and margin pressure converge.
Physician Fee Schedule
CMS’ CY 2027 Physician Fee Schedule final rule is positioning Medicare physician payment more explicitly around value-based prevention, primary care investment, duplicate-billing controls, and Medicare Shared Savings Program reforms—signaling that CMS is using the PFS/QPP/MSSP rulemaking cycle to tighten the link between fee schedule policy and accountable care strategy. For ACOs, medical groups, and payers, the strategic tension is that CMS is pairing VBC-aligned administrative simplification and MSSP strengthening with material physician payment pressure, including reported across-the-board cuts, which could strain specialist and primary care participation even as CMS seeks broader movement into accountable models. Premier framed the final rule as supportive of MSSP and burden-reduction goals, while coverage from Healthcare Innovation details the rule’s primary care, ACO, and billing changes ([Premier](https://premierinc.com/newsroom/policy/statement-pfs-mssp-cy2027-final-rule), [Healthcare Innovation](https://www.hcinnovationgroup.com/policy-value-based-care/medicare-medicaid/news/55417036/cms-finalizes-2027-physician-fee-schedule-with-changes-to-primary-care-acos-and-billing)).
Healthcare Workforce
Workforce capacity is becoming a core VBC execution risk: federal rural funding under the Rural Health Transformation Program is flowing disproportionately to workforce initiatives, signaling that CMS/HHS under the Trump administration sees staffing as a prerequisite for rural access, care management, and alternative payment readiness ([HFMA](https://www.hfma.org/fast-finance/workforce-leads-rural-grants/)). At the same time, Medicaid pressure, immigration-policy uncertainty, and persistent shortages in home-based and behavioral health workforces are shifting more care burden to families and weakening the labor base needed for longitudinal population health management, especially for dual-eligible, rural, and high-acuity patients. For ACOs, MA plans, and Medicaid risk-bearing entities, the strategic issue is no longer just clinician recruitment but redesigning care teams—primary care, behavioral health, home care, and technology-enabled support—around scarce labor while preserving access, quality, and trust ([NASHP](https://nashp.org/state-behavioral-health-workforce-surveys-can-strengthen-policy-and-planning/)).
Behavioral Health Integration
Behavioral health integration is shifting from “add a referral network” to accountable whole-person infrastructure: CMS payment updates, Medicaid access scrutiny, and outcomes-contracting playbooks are pushing ACOs, CHCs, and managed care plans to build measurable pathways across primary care, specialty behavioral health, oral health, and community-based crisis/intensive services. The near-term strategic tension is that VBC models increasingly depend on behavioral health access and risk management, while “ghost networks,” workforce shortages, and Medicaid program-integrity failures undermine attribution, care navigation, and outcomes accountability—making verified network adequacy, workforce data, and outcomes-based contracts central operating capabilities rather than compliance side projects. Recent commentary from the [National Council for Mental Wellbeing on outcomes contracting](https://www.thenationalcouncil.org/outcomes-contracting-solve-problems-starting-end/) and NACHC on [whole-person oral/behavioral health integration](https://www.nachc.org/whole-person-care-connections-between-oral-health-and-behavioral-health/) signals where health systems and payers are positioning: embedding behavioral health into routine touchpoints and tying payment to defined access, engagement, and functional outcomes.